DARE

Conviction 0HealthcareScan · Mon, Aug 10, 2026

DARE$1.36-3.21%

ResistanceSupportVol 14

Vol MA14 131.5K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Dare Bioscience, Inc.PHARMACEUTICAL PREPARATIONSwww.darebioscience.com ↗

Price1.36

Change-3.21%

Gap+0.71%

Rel volume0.34×

Avg volume191.75K

Avg $ vol263.36K

SMA 201.43

SMA 501.81

SMA 2001.92

Price vs 50-25.08%

Price vs 200-29.35%

MA stackbearish

50/200 crossdeath · 6d

Supertrenddown · 1.58

RSI (14)39

MACD hist0.03

MACD crossbull · 3d

Stoch %K / %D78 / 65

ADX (14)33

+DI / −DI16 / 28

RSI divergenceBullish

MACD divergenceBullish

ATR %+8.50%

ADR %8.69%

52w high3.27

52w low1.16

From 52w high-58.56%

Above 52w low+16.81%

New 52w highNo

SqueezeOff

Bollinger width83.48%

%B0.44

Donchian pos22.50%

Donchian high2.13

Donchian low1.13

AVWAP (52w high)2.37

vs AVWAP high-42.75%

AVWAP (52w low)1.30

vs AVWAP low+3.88%

OBV trendDown

Chaikin MF (20)-0.44

Today vs 20d0.34×

Avg vol (14d)131.5K

Avg vol (20d)191.75K

Avg $ vol (20d)263.36K

Market cap20.3M

RS 3m (vs SPY)-57.59%

RS 6m (vs SPY)-30.78%

RS line new highNo

Trend template0/8

Technical rank12.5

1 week+5.86%

1 month-32.92%

3 months-50.73%

6 months-19.82%

1 year-33.58%

YTD-30.51%

P/E-1.51

P/B27.64

P/S19.70

P/FCF-1.98

EPS-1.20

Div yield—

ROE—

ROA-48.15%

Debt/Eq0.01

Current1.03

EV/EBITDA-0.15

Gross margin—

Net margin—

Rev growth—

EPS growth-230.55%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value1.79M

Revenue152.46K

Net income-3M

Gross profit—

Free cash flow-10.27M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out14.98M

Employees24

ListedThu, Apr 10, 2014

Free float13.52M

Float %94.6%

Short interest601.25K

Days to cover6.0d

Short volume25.5%

Squeeze score34 / 100

Next earningsThu, Aug 13, 2026 · after (3d)

EPS forecast−$0.33 · 2 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank12.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.20

Support1.15

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DARE

All disclosures →

No recent disclosed trades by Congress in DARE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DARE

No recent insider (Form 4) filings in DARE. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in DARE · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.